- This event has passed.
The Role of OFEV® (nintedanib) capsules: Insights for the Health Care Practitioner
November 8, 2021 from 5:30 pm - 7:00 pm EST
Upon completion of this session, participants should be able to:
- Understand the safety and efficacy of OFEV for its latest indication
- Identify appropriate patients for treatment with OFEV
- Recognize the importance of having a multidisciplinary discussion when treating patients with OFEV
The purpose of this symposium is to provide an overview of the OFEV pivotal safety and efficacy data and provide case study examples to underscore the importance of identifying appropriate patients for treatment with OFEV. This presentation is made on behalf of Boehringer Ingelheim Pharmaceuticals, Inc.
Cedric Jamie Rutland, MD
Rutland Medical Group
CEO and Medical Director
UCR School of Medicine
Assistant Clinical Professor
Francesco Boin, MD
Cedars-Sinai Medical Center
Division of Rheumatology
Los Angeles, California
Credentials: Professor of Medicine Director, Division of Rheumatology Director, Scleroderma Center Kao Autoimmune Institute Cedars-Sinai Medical Center
This is not an official function/event of the American College of Rheumatology.